Nicolas Peguret
University of Lausanne
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Nicolas Peguret.
The Journal of Nuclear Medicine | 2016
John O. Prior; Nicolas Peguret; Anastasia Pomoni; Martin Pappon; Michele Zeverino; Bastien Belmondo; Alban Lovis; Mahmut Ozsahin; Monique Vienne; Jean Bourhis
Respiratory motion negatively affects PET/CT image quality and quantitation. A novel Pulsatile-Flow Ventilation (PFV) system reducing respiratory motion was applied in spontaneously breathing patients to induce sustained apnea during PET/CT. Methods: Four patients (aged 65 ± 14 y) underwent PET/CT for pulmonary nodule staging (mean, 11 ± 7 mm; range, 5–18 mm) at 63 ± 3 min after 18F-FDG injection and then at 47 ± 7 min afterward, during PFV-induced apnea (with imaging lasting ≥8.5 min). Anterior–posterior thoracic amplitude, SUVmax, and SUVpeak (SUVmean in a 1-cm-diameter sphere) were compared. Results: PFV PET/CT reduced thoracic amplitude (80%), increased mean lesion SUVmax (29%) and SUVpeak (11%), decreased lung background SUVpeak (25%), improved lesion detectability, and increased SUVpeak lesion-to-background ratio (54%). On linear regressions, SUVmax and SUVpeak significantly improved (by 35% and 23%, respectively; P ≤ 0.02). Conclusion: PFV-induced apnea reduces thoracic organ motion and increases lesion SUV, detectability, and delineation, thus potentially affecting patient management by improving diagnosis, prognostication, monitoring, and external-radiation therapy planning.
Journal of bronchology & interventional pulmonology | 2017
Alessio Casutt; Angela Koutsokera; Nicolas Peguret; Alban Lovis
Stereotactic body radiotherapy (SBRT) is an effective method for the treatment of localized primary lung tumors. Cyberknife, a highly accurate SBRT technique, follows the target during respiratory cycles using a metallic fiducial marker (FM) previously inserted into the lesion. Various methods have been described for the placement of an FM in peripheral pulmonary lesions; however, none of these is appropriate for mediastinal or hilar tumors. The placement of FMs in central lesions to achieve accurate SBRT is particularly relevant due to their higher mobility during respiratory and cardiac cycles. Here, we describe the use of linear-endobronchial ultrasound for the insertion of an FM marker in a centrally located metastatic melanoma, thereby allowing subsequent treatment with Cyberknife.
Radiotherapy and Oncology | 2012
Francesca Caparrotti; Sindy Monnier; Mohamed Laouiti; Palmira Caparrotti; Nicolas Peguret; Georges Vlastos; Nam P. Nguyen; Vincent Vinh-Hung
In a study of interobserver variations in delineating the breast for treatment planning, Reed et al. reported that interobserver differences were smallest at the breast skin surface, owing to the use of an automatically generated external skin contour [1]. Accordingly, the RTOG breast atlas extends the breast/chest wall CTV to the skin [2]. However, including the skin into the breast CTV is in discrepancy with planning studies that reported cropping CTV [3] or PTV to 5 mm [4] or 6 mm under the skin surface [5]. On one hand, including the skin can impact on the need to use a bolus or a skin flash technique [6], with consequently increased risk of skin toxicity. On the other hand, excluding the skin could cause an unwanted underdosage. There is a need to discuss whether the breast’s skin should be a treatment target or not.
PLOS ONE | 2017
Catherine Beigelman-Aubry; Nicolas Peguret; Matthias Stuber; Jean Delacoste; Bastien Belmondo; Alban Lovis; Julien Simons; Olivier Long; Kathleen A. Grant; Gregoire Berchier; Chantal Rohner; Gabriele Bonanno; Simone Coppo; Juerg Schwitter; Mahmut Ozsahin; Salah D. Qanadli; Reto Meuli; Jean Bourhis
Objectives Magnetic resonance imaging (MRI) of the chest has long suffered from its sensitivity to respiratory and cardiac motion with an intrinsically low signal to noise ratio and a limited spatial resolution. The purpose of this study was to perform chest MRI under an adapted non invasive pulsatile flow ventilation system (high frequency percussive ventilation, HFPV®) allowing breath hold durations 10 to 15 times longer than other existing systems. Methods One volunteer and one patient known for a thymic lesion underwent a chest MRI under ventilation percussion technique (VP-MR). Routinely used sequences were performed with and without the device during three sets of apnoea on inspiration. Results VP-MR was well tolerated in both cases. The mean duration of the thoracic stabilization was 10.5 min (range 8.5–12) and 5.8 min (range 5–6.2) for Volunteer 1 and Patient 1, respectively. An overall increased image quality was seen under VP-MR with a better delineation of the mediastinal lesion for Patient 1. Nodules discovered in Volunteer 1 were confirmed with low dose CT. Conclusion VP-MR was feasible and increased spatial resolution of chest MRI by allowing acquisition at full inspiration during thoracic stabilization approaching prolonged apnoea. This new technique could be of benefit to numerous thoracic disorders.
Journal of Medical Imaging and Radiation Oncology | 2017
R. Jumeau; Nicolas Peguret; Berardino De Bari; Raphaël Moeckli; Joao-Luis Soares-Rodrigues; Andrea Dante Durham; Sophie Hojnowski; Jean Bourhis; Mahmut Ozsahin; Catherine Beigelman-Aubry
Currently, routine radiotherapy (RT) planning for locally advanced lung cancer (LC) does not take into consideration the functional state of the lung. The goal of this study was to determine if it is technically feasible to integrate the sites of pulmonary emphysema (PE) into the RT planning process.
Radiotherapy and Oncology | 2016
Nicolas Peguret; Mahmut Ozsahin; Michele Zeverino; Bastien Belmondo; André-Dante Durham; Alban Lovis; Julien Simons; Olivier Long; Frédéric Duclos; John O. Prior; Alban Denys; Catherine Beigelman; Wendy Jeanneret Sozzi; Kathleen Grant; Véronique Gautier-Dechaud; Solange Peters; Monique Vienne; Raphaël Moeckli; Jean Bourhis
American Journal of Respiratory and Critical Care Medicine | 2017
Adam Ogna; Maurizio Bernasconi; Bastien Belmondo; Olivier Long; Julien Simons; Nicolas Peguret; Raphael Heinzer; Laurent P. Nicod; Jean Bourhis; Alban Lovis
International Journal of Radiation Oncology Biology Physics | 2014
B. De Bari; H. Bouchaab; Nicolas Peguret; Oscar Matzinger; V. Vallet; A. Wagner; D. Hahnloser; Jean Bourhis; M. Ozsahin
International Journal of Radiation Oncology Biology Physics | 2014
Nicolas Peguret; J.L. Soares Rodrigues; Jean-François Germond; B. De Bari; Jean Bourhis; E.M. Ozsahin
Radiotherapy and Oncology | 2016
Nicolas Peguret; Mahmut Ozsahin; Catherine Beigelman; Michele Zeverino; André-Dante Durham; Frédéric Duclos; K. Grant; Bastien Belmondo; Julien Simons; Olivier Long; Raphaël Moeckli; John O. Prior; R. Meuli; Jean Bourhis